From ABC 7 News:
ABC 7 Medical: Autism Vaccine
Posted: June 24, 2005 5:50 PM EST
URL: http://www.wjla.com/news/stories/0605/238268.html
-WJLA Script-
Anchor:
ANGRY PARENTS HAVE MARCHED ON CAPITAL HILL, DEMANDING TO CONGRESS THAT MERCURY
BE TAKEN OUT OF ALL VACCINEES.
THEY BLAME THE MERCURY THATS USED AS A PRESERVATIVE IN VACCINES FOR DAMAGING
THEIR CHILD'S BRAINS.
MEDICAL REPORTER KATHY FOWLER JOINS US NOW WITH THE DETAILS.
Kathy Fowler on set:
FOR SEVEN YEARS, LEADING SCIENTISTS HAVE TOLD THESE PARENTS THAT THERE IS
ABSOLUTELY NO LINK BETWEEN THE MERCURY IN VACCINE AND AUTISM.
BUT MORE RECENT STUDIES HAVE CHANGED THE MINDS OF SOME.
Story:
Deb Gordan: "My husband came downstarirs... and I looked at him and I said
Danny's autistic... he just broke down.. he said oh so that's it."
DEB GORDAN FOUND OUT HER 3 YEAR OLD SON, DANNY WAS AUTISTIC LESS THAN A YEAR
AGO... BUT TODAY SHE'S NO LONGER TREATING HIM AS AN AUTISTIC CHILD.
Deb Gordan: "Take the word autism away and just insert "poisoned by mercury" and
that's how I'm going to treat my child medically."
WHEN DEB WAS PREGNANT SHE GOT A FLU VACCINE AND THEN A DAY AFTER DANNY WAS BORN
HE GOT HIS FIRST VACCINE. DEB AND MANY PARENTS BELIEVE A PRESERVATIVE IN
VACCINES CALLED THIMEROSAL, WHICH IS MERCURY, CAUSED DAMAGE TO THEIR CHILDRENS'
BRAIN.
THE CENTER'S FOR DISEASE CONTROL SAY THERE'S NOT LINK...
Deb Gordan: "The vast majority of the scientific data does not support
association of thimerosal in vaccines with autism."
AT FIRST, SCIENTISTS LIKE DR. MARK GEIER, FORMERLY FROM THE NIH, TOLD CONCERNED
PARENTS THE VACCINE CONNECTION WAS RIDICULOUS...
Dr. Mark Geier: "DON'T bother us go away .. we're doing real research here."
BUT, GEIER, WHO'S RESEARCHED VACCINES SINCE THE 1970'S, DECIDED TO STUDY THE
CONNECTION BECAUSE OF THE SHARP RISE IN AUTISM CASES.
INTHE 1980'S ONLY ONE IN 2500 KIDS WERE DIAGNOSED WITH AUTISM... TODAY THE CDC
SAYS ONE IN EVERY 166 CHILDREN ARE CONSIDERED AUTISTIC.. A 15FOLD INCREASE.
DR. GEIER DIRECTLY COMPARED VACCINES WITH THIMOEROSAL TO VACCINES WITHOUT IT IN
RELATIONSHIP TO AUTISM.
Dr. Mark Geier: "We found a 6 times HIGHER increase in those that had the
theimoral."
THEY ALSO TESTED AUTISTIC CHILDREN AND FOUND THEIR MERCURY LEVELS WERE OFF THE
CHARTS. THEN THEY STUDIED OTHER RESEARCH DONE BY THE CENTER'S FOR DISEASE
CONTROL.
Dr. Mark Geier: "It said that they found a stiatiscially icnrease risk of
neurodevelopmetnal disorder following children with who go tthimeorsol adn the
more thimoersaol they got - the more the increase was."
DEB, WHO'S CONVINCED HER CHILD HAS BEEN MERCURY POISONED IS RESEARCHING A NEW
TREATMENT THAT DETOXES MERCURY OUT OF A CHILD'S BODY.
Deb Gordan: "I'm not giving up on him.... he's going to be okay.. mommy.. i love
you."
Kathy Fowler:
BRITAIN HAS ALREADY BANNED THE USE OF THIMEROSAL IN VACCINES... SO HAS TWO
STATES IN THE U.S. CALIFORNIA AND IOWA.
OVER THE LAST FEW YEARS, THIMEROSAL HAS BEEN TAKEN OUT OF MOST CHILDHOOD
VACCINES... BUT STILL REMAINS IN THE FLU AND TETNUS VACCINES.
FOR MORE INFO OF THIS TOPIC GO TO:
National Vaccine Information Center OR
http://www.generationrescue.org/

http://www.dmregister.com/apps/pbcs.dll/article?
AID=/20050626/NEWS/506260344/1001
Debated autism therapy gives hope to parents
Iowa boy improves with mercury-removal treatment
By TONY LEYS
REGISTER STAFF WRITER
June 26, 2005
Le Claire, Ia. - Gavin Wilken is out in his backyard, unknowingly demonstrating
extraordinary accomplishments. The 6-year-old is goofing around with his little
sister, Lindsey. He's talking. He's laughing. He's playing chase. Their mother,
Tami Wilken, watches from the kitchen, expressing amazement at how normal Gavin
seems. You should have seen him a few years ago, she says. He quit speaking. He
failed to respond to his name. He would hold a pen in front of his face and spin
it for hours on end.
The troubles began subtly when Gavin was 17 months old. "He started swaying in
front of the wall," Wilken says. "At first, I thought, 'How cute, he's playing
with his shadow.' But there was no shadow." Doctors, who at first saw nothing
wrong, concluded Gavin had autism. The brain condition can rob children of their
personalities, and it can tear families apart. Most doctors say they're unsure
what causes autism, and they can't explain why the number of new cases has
soared over the past 20 years. They have little to offer in treatment or in
hope.
Tami Wilken says she knows the answers. She has joined an increasingly vocal and
controversial movement of parents who believe their children's autism was
sparked by mercury, which until recently was included in many vaccines as the
base component of the preservative Thimerosal. Wilken has taken the belief a
step further, seeking out an aggressive treatment, called chelation, to remove
the metal from Gavin's body.
She knows mainstream medical leaders disagree with the theory and the treatment.
"If their oath is to do no harm, why are they pushing mercury into my child but
not letting me take it out?" she asks. Doctors skeptical of treatment's
benefits. This spring, Gavin became one of 125 children put forward as success
stories by a new national group urging parents to use chelation to relieve their
children of autism. The group, Generation Rescue, has taken out full-page ads in
USA Today and the New York Times, declaring that "Autism is Preventable
and Curable." The effort concerns many physicians, who worry that it could make
parents needlessly fearful of vaccines and that it could lead desperate families
to spend tens of thousands of dollars on a treatment that they say probably
doesn't help and could hurt.
Doctors often start the discussion by saying they understand why parents of
autistic children are frustrated with the lack of explanation and treatment for
the growing problem. Federal researchers say that between 1994 and 2003, the
number of school-age children classified as having autism or related disorders
exploded from 22,664 to 141,022. Official estimates say as many as one in 166
children are affected. Although many experts say that much of the jump in cases
is due to more aggressive diagnosis of the condition, most agree that
there also has been an actual increase.
Dr. Patricia Quinlisk, Iowa's state epidemiologist, says large studies have
concluded there is no link between mercury and autism. "Thimerosal is not the
cause of autism," she says. "Therefore, I don't think taking it out is the
answer." Several European countries took the preservative out of their vaccines
years ago, she says, and their autism rates continue to grow. American drug
makers began removing the controversial ingredient from most of their vaccines a
few years ago. "The anti-vaccine people took that as proof something was wrong,"
Quinlisk says. In fact, she says, the manufacturers did it because authorities
feared that even baseless concerns could make parents avoid important
vaccinations.
"No way it could be a coincidence"
Chelation, the treatment being used on Gavin, has been around for many years. It
mainly has been used for people who have suffered from lead poisoning or
industrial accidents involving heavy metals. Chelation medications are designed
to bind with the metals, which the body then can excrete. Possible side effects
include loss of helpful minerals, such as zinc and iron. Gavin has been taking
various forms of the treatment for four years . His current medicine is a cream
that his parents spread on his arm every other day. They give him vitamins and
other supplements to try to replace lost minerals. Tami Wilken, who works part
time at the International House of Pancakes, and her husband, Bill, who drives
trucks for FedEx, have spent $65,000 to $70,000 on treatment for their son.
It is worth it, they say. Gavin resumed speaking within two weeks of starting
chelation. Within a year, he was using six-word sentences. This past school
year, he was in a regular first-grade class with the help of a teacher's aide.
They hope that by third grade, he will be
able to handle classwork on his own. Quinlisk and many other doctors say some
autistic children improve on their own, for unknown reasons. So the fact that
some kids get better
while on a given treatment proves nothing, they argue. Tami Wilken doesn't buy
it. "Absolutely not," she says. "There is no way it could be a coincidence."
Source of autism remains unclear
J.B. Handley, Generation Rescue's founder, doesn't buy it either. Handley, who
lives in Oregon, has an autistic son who he says is improving while having
chelation treatment. Authorities are so intent on vaccinating children that
they've covered up the harm, and studies concluding otherwise are tainted by the
influence of drug companies, Handley says.
Handley contends that all autism is caused by mercury and that because of the
preservative that used to be common in vaccines, "an entire generation has been
poisoned," he says. That cuts against conventional wisdom, which holds that
autism is a complicated, varied condition that probably has multiple causes.
Handley says the symptoms of autism are strikingly similar to those of mercury
poisoning. That's why he believes chelation works.
The treatment has caused controversy before. In 1998, the Iowa Board of Medical
Examiners suspended a West Des Moines doctor partly for using chelation as a
treatment for heart disease and diabetes. The doctor still hasn't had his
license restored.
Under state rules, the treatment may be used only to treat heavy-metal
poisoning. Ann Mowery, the licensing board's executive director, says she hasn't
heard of any Iowa physicians using the treatment for autism. She says the board
hasn't ruled on whether that would be a permitted practice, because the subject
hasn't been brought up.
Gavin's physician, Dr. Robert Filice of suburban Chicago, knows his
"alternative" therapy is outside the medical mainstream. But he says he's not
worried about getting in trouble for it because chelation is intended to take
out heavy metals, and that is precisely how he's using it.
Filice is not sure that all autism cases are caused by mercury poisoning, but he
believes that even small amounts of the metal can harm children who for genetic
reasons have trouble excreting it. The doctor says he's treated about 20
autistic children with chelation, and about half of them have shown dramatic
improvement. "There's no guarantee that they're going to respond. But it's such
a safe therapy, with the potential benefits being so great, I would tend to err
on the side of treating somebody, just to see what happens."
Such talk leaves many people wondering if chelation is the answer, or if it is
just the latest straw for desperate parents to grasp.
More research urged on mercury's role
Count Steven Muller among the undecided. Muller is executive director of the
Homestead, a Runnells autism treatment agency. He sympathizes with families who
are reaching out for unusual solutions.
"It's great to have people pushing the envelope, because if they don't, the
world stays flat," he says. "But I've also heard people say that all autistic
kids can be cured, thereby raising false hopes for families that probably always
will be dealing with this."
Muller's agency relies heavily on behavioral therapies to help autistic children
and adults get along in the world. He believes there is enough suspicion to
justify continued studies of Thimerosal's possible role. Even now that the
preservative has been removed, he suggests that doctors should consider
spreading the shots out, instead of giving them in bunches. That might lessen
possible complications, he says.
"But when parents say, 'I'm not going to vaccinate my kids,' that's the wrong
approach," Muller says. "You do need to vaccinate your kids." Muller is wary of
expensive, unproven treatments. He has seen families go into debt to pay for all
kinds of approaches, from swimming with dolphins to taking complicated vitamin
therapies. Some might work for a few kids, he says, but not for everyone.

Subject: ABC News: Actress chelates after mercury poisoning
Actress Describes Mercury Poisoning OrdealDaphne Zuniga Was Eating a High
Seafood Diet
By LIZ BOROD WRIGHT
Oct. 21, 2005 — - Fish had become large part of Daphne Zuniga's diet. She was
eating what she described as "your average Hollywood stay-in-shape diet, a ton
of fish and low carbs."
"I was eating tuna four times a week," said Zuniga, who stars in the ABC Family
series "Beautiful People." "I would go out for sushi and think, 'Oh great, at
least we're not going for Italian, with all the oil and carbs.'"
She was also experiencing an array of mysterious health problems. In addition to
severe headaches, she had cramping in her fingers and feet. She also frequently
felt "a sort of tingling, as if someone was tickling you, all up and down my
body and on my legs, and it got more and more pronounced," she said.
Mercury poisoning can also affect your cognitive functioning, and Zuniga, 43,
found that she was unable to remember her lines -- even if she had learned them
the night before.
"I had crying spells, low-grade depression, loss of memory, and brain fog, which
is where I would be talking to you and I would get disoriented," she said. Then,
in February 2004, after eating sushi four times in one week, Zuniga broke out
into an itchy rash all over her body that landed her in the emergency room. She
saw all sorts of doctors, but no one mentioned mercury poisoning.
In October, Zuniga asked her doctor about whether she might have mercury
poisoning after she read an oft-quoted statistic from an EPA study: that one in
six women of childbearing age has elevated mercury levels. Sure enough, the
level of mercury that showed up in a blood test revealed that she was
significantly over the safe level.
Road to Recovery
Zuniga immediately stopped eating seafood, and has no plans to start again. She
also embarked on treatment to rid her body of the mercury. Her doctor gave her
regular chelation injections, which helps the body excrete heavy metals through
urine. She also took supplements she found at the health food store that contain
natural chelating ingredients. [It's important to note, however, that taking
chelating supplements on your own and not under a doctor's care can be
dangerous.] Six months later, her symptoms of cramping and tingling were gone.
Her mind was much clearer and her mood had improved. Zuniga still drinks shakes
with protein powder that contains glutathione, a protein that binds to toxins
like mercury and helps the body get rid of them.
Mercury Ignorance
Despite her ordeal, Zuniga still encounters her share of skeptics. "People don't
want to acknowledge the effects of mercury; [they] will say things like, 'Oh,
that's our society, we're so overstimulated,'" she said. "I have experienced the
difference between the disconnected brain fog and the clarity," added Zuniga,
who is working with the Turtle Island Restoration Network, a California
environmental group, on their campaign to inform the public about mercury. Right
now, this group is trying to get the national supermarket chain Safeway to post
signs in all of its supermarkets warning about the dangers of mercury in fish.
Copyright © 2005 ABC News Internet Ventures

From Monsters and Critics.com
Consumer Health
The Age of Autism: Gold salts pass a test
By Dan Olmsted
Dec 23, 2005, 19:00 GMT
In a Striking Follow-up to Our Reporting on the First Child Diagnosed with
Autism -- and His Improvement After Treatment with Gold Salts -- a Chemistry
Professor Says Lab Tests Show the Compound Can \'reverse the Binding\' of
Mercury to Molecules.
\'This does lend support to the possible removal of mercury from biological
proteins in individuals treated with gold salts,\' Boyd Haley, professor and
former chemistry department chair at the University of Kentucky, said Thursday.
The potential significance: Donald T. -- Case 1 among children diagnosed with
autism in the 1930s -- showed marked improvement in his autistic symptoms after
being treated with gold salts for an attack of juvenile rheumatoid arthritis.
That`s according to his brother, who we interviewed earlier this year in the
small Mississippi town where he and Donald, now 72, still live.
One theory of autism -- strongly dismissed by federal health authorities and
mainstream medical groups -- is that the disorder is primarily caused by a
mercury preservative called thimerosal that was used in vaccines beginning in
the 1930s. Some parents and researchers who believe autism is, in essence,
mercury poisoning are using treatments designed to remove mercury from the body
or offset its neurological effects.
Haley is among a minority of scientists who holds this view, and after reading
about Donald`s improvement he set out to test whether gold salts have any effect
on mercury. \'You follow your nose in research, and when I saw that I thought,
yes, this is a possibility,\' said Haley.
Haley`s experiment was quite simple: He began with a colored thiol-containing
compound. Thiols are the class of molecules that contain a sulfhydryl group (a
sulfur and hydrogen atom bound together) and, because of the affinity of mercury
for sulfur, these molecules bind tightly to mercury. Thiols are found in most
enzymes, and when mercury binds to them, these enzymes lose their biological
activity, which is needed to maintain healthy cells, he said.
Haley performed two tests involving inorganic mercury -- the type of mercury
thimerosal breaks down to in the brain, he said.
Haley`s compound was designed to turn colorless when mercury binds to it. In the
first test, he added the mercury, and the \'optical density\' measurement went
from 0.23 units down to 0.11 units immediately, and down to 0.03 units in half
an hour -- a clear sign that the mercury had bound to the thiol.
In the second test he premixed the mercury with gold salts for two minutes, then
added it to the same solution. This time the optical density dropped to 0.11 but
then slowly increased back up to 0.23 within about 30 minutes -- \'totally the
opposite of the situation with mercury alone,\' Haley said. \'The only way this
could happen would be for the gold salts to remove mercury from the thiol-containing
compound.\'
The advocacy group SafeMinds -- which opposes the use of mercury in medicines
and provided Haley with the $142 prescription of gold salts to test -- called
the results potentially significant but cautioned against premature use of the
compound to treat autistic people.
\'Clinicians have shown that some autistic children show strong recovery from
their symptoms after biomedical treatment,\' said SafeMinds` Mark Blaxill. \'So
any time we discover a treatment that works in a child, we need to take it
seriously.
\'According to his brother`s unprompted report, Donald T. recovered from autism
after treatment with gold salts. We should be all over that, especially after
Boyd`s work. But we need to proceed with care to make sure that this is a safe
treatment.\'
Haley made the same point. \'Please note that I am not recommending using gold
salts to treat autistics, but it would certainly be worth a project if carefully
monitored by a physician in a good clinic.\'
In August Donald`s brother described to us his \'miraculous response\' to
gold-salts treatment for a life-threatening attack of juvenile arthritis. Donald
was given injections of the salts over a two- to three-month period at the
Campbell Clinic in Memphis at age 12 in 1947.
The arthritis cleared up, and so did the \'extreme nervousness\' and
excitability that had afflicted him, his brother said. Donald also became \'more
social.\' He went on to college, where he was invited to join a fraternity;
worked as a bank teller; and now, in retirement, pursues his love of golf and
travels the world. Most of those early patients -- and thousands since -- were
institutionalized when they got older or lived in extremely sheltered
circumstances, according to follow-up reports. (Donald did not respond to our
request for an interview, and we are not identifying him at this time beyond
information in the original case study and follow-up.)<!--page-->
Before Haley tested the gold salts, he told us why he thought it was worth
investigating.
\'Nothing has a higher affinity for mercury than elemental gold. They form bonds
that are very tight,\' Haley said. Devices designed to detect and filter out
mercury routinely use gold, he noted -- and they obviously would employ a less
expensive element if gold weren`t so effective. Mercury was also used to extract
gold from ore in mining operations.
In the body, Haley said, gold likely is \'attracted to the same places as
mercury. They would probably make it to the same spot in the body. It (gold)
would probably cross the blood-brain barrier like mercury. There are reasons to
think that if you put it in, it would chase mercury down because they`re very
similar in their chemistry.
\'So you might be able to displace it with the gold. The chemistry gets
complicated here, but gold does not do as much oxidative stress as does mercury.
The gold isn`t nearly as toxic as the mercury. ... It could take it off the
enzyme it`s inhibiting and reactivate that enzyme.\'
Haley said he was intrigued that the treatment may have benefited Donald when he
was 12 -- old for such a positive response, according to proponents of
biomedical therapies. The most controversial such treatment is chelation, which
uses drugs in an attempt to pull toxic metals -- mercury in particular -- from
the body.
\'It doesn`t seem to work with the older kids,\' Haley said. \'These older kids
are just lost.\' But, Haley emphasized: \'Don`t jump on this. Be careful. You
can hurt kids.\'
That concern was underscored when a 5-year-old autistic child died this year
while undergoing chelation in Pennsylvania. Federal officials say it is not a
responsible practice, although one advocacy group says more than 10,000 families
have tried it, with significant benefit.
This Ongoing Series on the Roots and Rise of Autism Welcomes Reader Comment.
E-Mail: Dolmsted@upi.Com
© Copyright 2003 - 2005 by monstersandcritics.com.
This notice cannot be removed without permission.
http://news.monstersandcritics.com/lifestyle/consumerhealth/article_1071179.php

Treating Autism One Wave at a Time
'The worst part about regressive autism...is that it catches parents off
guard.'
By James Ottar Grundvig for The Epoch Times.
http://www.theepochtimes.com/aboutus.html
This February will mark the one-year anniversary in treating my autistic
son's physical condition, and not merely treating him with psychology modalities
that included speech therapy, Applied Behavioral Analysis (ABA), and a host of
other special education therapies. What's significant about this date is
threefold.
First, the infusion of the vitamins and nutrients that had been absent
from his diet the day it collapsed at the age of two started the recovery.
Second, the evolutionary steps of the treatment plan successfully identified and
addressed his core issues. Third, the gradual implementation and phasing of the
plan in four waves proved nimble and wise. What once seemed hopeless-from
dropping the wall of denial that autism is a problem the child will outgrow, to
securing special education services for the mysterious disorder-now is a journey
through a deep valley rather than one trapped in a giant maze. The trek has been
long and difficult, but the end goal is in sight and the direction well defined.
The worst part about regressive autism, found in most Pervasive
Developmental Disorders (PDD) children, is that it catches parents off guard.
The speech goes. The fine-motor skills go, too. The diet shrinks due more to
texture of food than taste. The great start to a baby's life in terms of
learning and development are turned upside-down. In essence, the body and brain
are at once under assault. That's because in many autistic
cases, the infants have been unable to filter out heavy metals. In turn, this
accumulation has zapped their central nervous system. And that amplifies the
senses and yet shrinks their view of the world from panoramic to monocular
fritted with chaos.
Finding a doctor who understands the bio-neurotoxin roots of autism
spectrum disorders (ASD) is crucial. Finding one who will listen without forcing
a treatment program prior to identifying the issues of an ASD child is equally
important. Still, before the results from a battery of blood and urine tests
come back, physicians, whether DAN (Defeat Autism Now!) or internists, can
address a collapsed diet by issuing a palette of vitamins and minerals that most
likely has been missing in a child. The tests are done to detect food
"sensitivity" (not allergy) and see whether there is an unnatural balance in
essential metals, such as copper, iron or magnesium, which are good for you, but
not in excess. A red blood cell analysis test or a 24-hour urine "challenge"
test will also show if there is the presence of toxic heavy metals, like
arsenic, lead, mercury and cadmium, which were found in my son, Fridrik.
If that double-edged sword of news-good because the core problem has been
identified; bad because the child has been poisoned-returns with harmful metals,
it will allow the doctor to take the next key step. And each doctor, depending
on his protocol, will handle it differently.
It took a couple of physicians who insisted on treating Fridrik for
ailments found in many ASD kids but not him, to find the right doctor. Located
in Stamford, Connecticut, one hour outside New York City, an internist who
practices environmental or "integrated" medicine stepped to the plate. It didn't
bother me that he had never treated an autistic child before. He has been
chelating adults contaminated with heavy metals and Alzheimer's patients, using
many of the techniques that DAN doctors do. More important, he listened,
learned, and quickly adapted his protocol to meet Fridrik's needs.
On top of the vitamins, the doctor prescribed a daily routine of giving
Fridrik antioxidants, a formula tailored to my son's amino acids profile, and
Phosphatidyl Choline (PhosChol), a brain neurotransmitter. That was the
foundation of the first wave.
Since Fridrik's mother is a nurse, we began to give an intravenous
glutathione injection, the brain's natural chelator, for a ten-week period every
other day at home. During visits to the doctor's office, Fridrik received an
injection of glutathione and PhosCol. This second wave ignited a quantum leap
progress in his speech. It also confirmed the lab results of heavy metals
toxicity. Had his own glutathione been working they way it's designed by nature,
then there would be little improvement in his speech and
ability to focus in such a short period of time.
The third wave, chelation (DMPS) therapy has been the one weighted with
the most risk. The decision came down to knowing that he, likely many other ASD
children who have been chelated, would regress for a three-month period or
worst. And watching the sad regressive tics resurface was painful to watch. Why
does that happen? It is due to the mercury being "declawed" (the Greek word for
chelation) and purged as it passes through the brain. Imagine sweeping dust out
of the attic. Although you can sweep a lot of it down the hole, much of the dust
is kicked in the air. When it settles, the mercury zaps the brain and nervous
system a second time. As we begin the sixth month of chelation, knowing Fridrik
is "dumping" a lot of mercury, in the long run it was best to interrupt the
progress that glutathione made in his speech by making sure that we extract the
bulk of the metal out of his system.
By the end of 2005, I learned of a protocol that uses a "methB-12"
subcutaneous shot that was developed by a New Jersey DAN doctor. Given every
third night, the B-12 subQ has helped Fridrik with speech during the regression
caused by chelation, just as glutathione did prior to it. But it also helped his
once restless slumber by allowing him to sleep the night through.
This fourth wave, combined with the other treatments over the year have
allowed his body to adjust, to heal itself, to take big strides in recovery.
These treatments in concert with special education therapies have given him a
fighter's chance that one day he will be "mainstreamed" and join his peers in
growing up.
Coming home the other day and seeing my son sit in front of the window,
pushing his ears forward like radar dishes so he could hear the reflection of
his own voice confirmed that we are on the right track. But two years of
poisoning by vaccines and other sources has become a two-three year program to
detox my son of the heavy metals that have damaged parts of his brain, that have
kept him in a dark fog, and that have stolen his childhood.
James Ottar Grundvig lives and works in New York City. He has an autistic
child.

http://www.autismspeaks.org/science/research/toxicology_summary.php
Toxicologists Gather to Discuss Autism Spectrum
Disorders
Workshops Highlight Environmental Influences, Chelation
The cause and treatment of autism spectrum disorders was the focus of two
dedicated sessions at the annual meeting of the Society of Toxicology, held in
Charlotte, N.C., in March 2007. More than 6,000 toxicologists convened to
interact and present the most recent data in toxicology affecting a wide number
of organ systems, including the brain.
The first autism-related session offered an overview of the role of the
environment in autism, allowing toxicologists to discuss new avenues of research
to study gene–environment interactions in a multidisciplinary setting. The
second session focused on the use and efficacy of chelation in heavy metal
poisoning and relationship to autism spectrum disorder.
Search for Clues in the Environment
A March 26 workshop, entitled “Environmental Risk Factors for Autism: Search for
Clues,” was organized by Autism Speaks/CAN-funded researcher Dr. Ellen
Silbergeld from John's Hopkins University. The workshop presentations spanned
multiple disciplines, and highlighted evidence that multiple environmental risk
factors may contribute to the development of symptoms of autism.
Dr. Craig Newschaffer started off the workshop by illustrating the
“epidemiological triangle,” that is, counting people affected by a disease as a
triad across the person, the time, and the place in which they live or are
counted. In the case of autism, there is a concern over the change in prevalence
over the past 10 years, especially since the recent publication of the MMWR
report (click here to read more), which reported an increase in prevalence to 1
in 150 children.
Because of multiple environmental factors (including increased awareness of this
disorder) and diagnostic criteria changes, it is hard to parcel out the effect
of any one particular exposure using epidemiological data. In fact, it is easy
to misinterpret many studies that simply show a correlation of an increased risk
of autism due to any one environmental risk factor. Correlation between two
variables does not imply causation and studies which do so should be viewed with
caution as they can lead to false positives. Newschaffer emphasized that this is
a complex disease with a highly heritable component. Therefore, biologically
plausible candidates as environmental risk factors should be explored by
toxicologists.
Genetic Candidates Provide Scientific Leads
Following that line of reasoning, Pamela Lein from Oregon Health Sciences
University, Isaac Pessah from UC Davis (and recipient of the CAN environmental
innovator award) and Patricia Rodier identified possible exposures which may
interact with known gene candidates.
Lein, an expert in environmental effects on genes that regulate development of
the nervous system, hypothesized that genetic factors that interact with
environmental exposures lead to a disruption of neurodevelopment. She pointed
out several known examples and ideas for future research. For example, gene
mutations of proteins MET, Wnt, semaphorin, reelin, neuroligins, engrailed and
ephrins, have all been linked to ASD's through genetic screens and genetic
studies.
As they participate in aberrant neuronal connectivity, synaptogenesis and
neuronal connectivity, disruption of the normal function of these genes can lead
to severe neurological symptoms. Therefore, the effects of environmental
toxicants should be studied more closely on the expression of these molecules.
Alternatively, the behavioral effects of toxicants or environmental agents in
animals which show mutations of these genes should be performed. The abnormal
expression of these molecules could help explain the imbalance of inhibition vs.
excitation in different brain regions. This imbalance has been observed by other
researchers studying the disorder and may serve as one of the mechanisms behind
many abnormal behaviors.
Looking specifically into how neurons function on a more basic biological level,
Pessah has made important contributions to the understanding of the role of the
CaV1.2 receptor in autism. Mutations of this receptor have been reported as the
cause of Timothy Syndrome. Around 60 percent of individuals with Timothy
Syndrome show symptoms of autism, making this molecular target of interest to
many toxicologists and neurobiologists. In addition to this receptor's role in
calcium signaling, which controls cellular processes, it is also present on
immune cells. This means that this mutation, along with other mutations that
also affect calcium signaling, may contribute to symptoms in ASD via dysfunction
in the immune response.
Together, Lein and Pessah presented evidence of specific molecular and genetic
targets where environmental exposures may lead to disrupted neurobiological
function relevant to understanding ASD.
The Immune System: Target of Toxins or Predisposing Factor?
Both Pessah and Silbergeld emphasized the role of the immune system in ASD, as a
potentially important area for evaluating environmental toxicant exposure, as
well as interactions between genetic susceptibility and environmental agents at
the level of genes which regulate the immune system.
Because of the complexity of ASD, there are likely many different causes of
autism and, accordingly, many different risk factors which may contribute. While
current diagnostic techniques integrate the range of neurobehavioral deficits
and other symptoms in ASD, disaggregation of the many forms of ASD may provide
more accurate clues of which genes and which exposures are responsible for
autism spectrum disorders.
While observational and biological markers of immune dysfunction have been
observed in some children with autism, these markers have not been organized
into different subsets of clinical symptoms. Silbergeld pointed out some
convergent mechanisms by which mercury exposures could contribute to ASD. She
concluded by pointing out that genotype, which might contribute to immune system
changes, can serve as an underlying susceptibility for which different triggers
produce disease. In this way, environmental triggers or exposures have different
effects based on a predisposing susceptibility. While some individuals are
vulnerable based on genetics or early exposure, others are not affected by these
same environmental risk factors.
Risk Factors Previously Identified:
In addition to unknown environmental factors, Rodier at the University of
Rochester reported her findings on five known pharmaceutical and environmental
factors which result in higher odds ratios for developing autism after
exposures. These include: valproic acid, thalidomide, rubella, misoprostol and
ethanol.
She pointed out that in addition to their teratogenic effects, exposure to these
agents led to some symptoms and features that resembeled autism when
administered during specific critical times in gestation. Together with
colleagues at the University of Rochester, she also demonstrated that both
children and animals exposed to valproic acid in utero demonstrated similar
responding on a learning task which is dependent on normal functioning of a
brain region called the cerebellum. This parallel in behavioral functioning may
be due to alterations in expression of a gene called HOX1A, or it may be the
result of more subtle “epigenetic” changes which affect gene expression.
Role of Epigenetics
Epigenetics refers to mutations that can be passed on from generation to
generation without modifications of the DNA sequence. This can be done by
chemically modifying different parts of the DNA code, which either turns on or
turns off gene expression. Of interest, instead of observing changes in the DNA
code, chemical modifications can be made to the DNA, or to the proteins which
pack DNA.
Importantly, these epigenetic modifications can be inherited, occur
spontaneously, or they can be targets of environmental factors. These sorts of
“epigenetic” changes have been studied in autism spectrum disorder and may not
only be the target of pharmacological agents, but other non-toxic environmental
exposures including diet and social experiences. This means that environmental
exposures may include neurotoxic agents, but should not be restrictive in
definition.
Summary and Conclusions
Together, the speakers urged the over 150 toxicologists who attended this
workshop to consider studying autism as a multifactorial disease, incorporating
genetic and environmental influences and requiring multidisciplinary research
teams. In addition, the immune system should be considered as target or a
predisposing factor to a number of environmental exposures in autism. Finally,
environmental exposures and toxins for study should be carefully chosen based on
their biological plausibility in producing neurobiological and behavioral
symptoms characteristic of ASD.
Utility of Chelation Therapy Highlighted
In the March 27 workshop, Donald Smith from the University of California Santa
Cruz and Barbara Sturpp from Cornell University organized a symposium on
“Advances in the Efficacy of Chelation Treatment to Alleviate Neurocognitive
Effects of Lead and Autistic Spectrum Disorders.”
Smith pointed out that the use of the chelating agent succimer (otherwise known
as Chemet®, or meso 2, 3-dimercaptosuccinic acid, DMSA) is FDA-approved for use
in cases of lead poisoning only. However, this treatment is being used in a
variety of neurological disorders, including autism.
While the practice of using chelation therapy is becoming more common, the
benefits and risks of this treatment are not well studied. Therefore, the
purpose of this workshop was to highlight recent clinical and animal model
studies to address the possible risks and benefits of chelation treatment for
metal poisoning.
Lessons for the “TLC” Study
The benefits of chelation to treat individuals with severe lead poisoning have
been well established. However, prior to the mid-1990s there was little evidence
to demonstrate the benefits and possible risks of chelating children with mild
to moderate, or ‘subclinical' lead poisoning. Cognitive impairments including
behavioral, attention, memory, and IQ deficts can occur at lead levels lower
than what has historically been considered “toxic”.
In order to determine the beneficial effects of succimer chelation at these
lower exposure levels, a NIH-funded multicenter, placebo-controlled randomized
clinical trial in children with moderate (below 45 micrograms/deciliter) blood
lead levels was conducted. Kim Dietrich from the University of Cincinnati, an
investigator in this study (termed the Treatment of Lead Poisoned Children, or
“TLC” study) presented his findings, which were originally published in 2004.
This study investigated the effects of chelation or placebo in lead-exposed
children who were chelated as toddlers and followed them up at 7 1/2 years of
age. Children were administered a battery of tests which examined cognitive,
learning, memory and behavioral domains. Their results showed that children
receiving succimer chelation did not perform any differently on these measures
compared to those receiving a placebo.
The authors concluded that because chelation showed no beneficial effects on
cognitive performance, this study reinforces the importance of preventing or
limiting exposure to lead in the environment to eliminate childhood lead
poisoning.
Recent Evidence to Suggest Caution
Lead exposure in animal models and humans has been shown to produce cognitive
deficits, and these cognitive deficits have been alleviated by succimer
chelation treatment in animals. Recent studies published in Environmental Health
Perspectives and Neurotoxicology and Teratology examined the effects of
chelation in animals treated during development with differing lead levels (no
lead, moderate, and high lead).
These studies also examined succimer chelation therapy in animals that had not
been exposed to lead. The authors report that while the succimer treatment was
beneficial in lead exposed animals, it appeared to produce some long-term
detrimental effects in those who were not exposed. While chelation treatment
paradigms differ in animals and in clinical practice, the authors of this report
urge caution in administering chelating agents to individuals who do have not
show evidence of heavy metal exposure.
Chelators help remove heavy metals from the body by forming chemical bonds with
metals (such as lead and mercury), which facilitates excretion of these chelator/metal
complexes through the urine or feces. Therefore, individuals undergoing
chelation may show a reduction in blood levels of these toxic metals accompanied
by an increase in their urinary excretion. However, in animal studies of lead
poisoning, these changes were not well-associated with reductions in brain lead
levels, leading researchers conclude that the use of blood lead levels as a
marker of metal reductions in other tissues such as the brain may overestimate
the potential benefits of chelation.
This suggests that clincial chelation as currently practiced may reduce uptake
of heavy metals into the brain but may not sufficiently remove what is already
there. Therefore, the mechanism by which chelation alters cognitive performance
in individuals with mild to moderate metal exposure needs further study.
Chelation Use in Autism Spectrum Disorders
The role of heavy metals such as mercury in autism has been heavily debated, and
many parents are turning to chelation as a potential treatment. Dr. Elizabeth
Mumper presented her findings from treating children at the Advocates for
Children Pediatric Clinic in Virginia.
She reports that she has treated 280 children with autism who showed altered
metabolism of porphyrins in blood and urine. She uses this disruption in
porphyrin levels as an indirect marker for heavy metal exposure, and in addition
noted that these patients show a disruption in the methionine synthase pathway,
also measured in urine and blood. In addition to chelation therapy, children
receive vitamin supplementation to compensate for possible loss of essential
metals lost during succimer treatment.
Although no statistical analyses were conducted on the effectiveness of
chelation therapy in children with autism, Dr. Mumper has cited positive
responses from parents who report an improvement of symptoms following oral
succimer chelation therapy as part of the DAN! protocol.
Summary and Conclusions
The panel of experts convened to discuss and present this topic emphasized the
need for studies which show the molecular actions of chelation for efficacy and
adverse events. In addition, research needs to be conducted to resolve
inconsistencies between animal models and human data. In order to protect
against depletion of essential minerals during chelation, studies need to
evaluate the mobilization and excretion of essential trace elements during
long-term chelation to determine whether vitamin and mineral supplementation
offers protection against possible adverse effects of chelation.
back to top Autism Speaks Canada Autism Speaks UK Privacy Terms of Service
Contact Us
© 2007 Autism Speaks Inc.
Autism Speaks and Autism Speaks It's Time To Listen & Design
are trademarks owned by Autism Speaks Inc. All rights reserved.
Back to page